The company will use the money to accelerate pivotal trials and prepare for commercial launch of the Stentrode BCI system.

The workforce reduction is part of a restructuring designed to improve accountability and accelerate growth and innovation.

The collaboration will pair biometric data from the Oura ring with data from glucose sensors and insulin pumps.

However, the sequencing company said it remains on China’s unreliable entity list, and it is working toward a long-term ...

Siemens Healthineers has reaffirmed its expectation that the negative impact of tariffs will double in its next fiscal year ...

CEO Ivan Tornos said multiple factors emerged late in the quarter that caused the shortfall. Zimmer’s shares plunged more ...

Medtronic reached a critical juncture last month in its quest to build the market for renal denervation, a new device-based ...

Qiagen has identified Parse Biosciences’ technology as complementary to its sample technology and bioinformatic businesses.

In a letter to CMS Administrator Mehmet Oz, diabetes caucus leaders raised concerns that the agency’s proposals will reduce ...

A software defect could cause the app to terminate, resulting in missed alerts or alarms. Dexcom required users to update the ...

More than 30 organizations, including AdvaMed and the American Clinical Laboratory Association, are pushing for a permanent ...